GGrantIndex
← Leaderboards

Steven Shoptaw

University Of California Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗
$45,062,464
Attributed
$69,777,330
Total exposure
29
Grants
17
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $24.7M · FY2005–25
$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$151,475,190 · 33

By mechanism

UG1$75,812,111 · 9
P30$26,225,567 · 9
U01$25,658,715 · 2
P50$14,817,470 · 4
R01$5,502,869 · 4
P60$1,659,038 · 2

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Innovation”

Research focus

InnovationResearch PersonnelCommunitiesLos AngelesAids PreventionScientistCaliforniaScienceCollaborationsMethamphetamineCaringAreaResponsePublic HealthResourcesProgramsUniversitiesMemberBehavioralFundingPreventionFosteringPersonsEpidemic

Grant awards (162)

NIDA Clinical Trials Network: Big South/West Node (CTN-0132 and CTN-0139)$5,606,566
UG1 · FY2025 · DA
Project-003$5,606,566
UG1 · FY2025 · DA
NIDA Clinical Trials Network: Big South/West Node (CTN-0159)$3,235,924
UG1 · FY2025 · DA
Project-003$3,235,924
UG1 · FY2025 · DA
NIDA Clinical Trials Network: Big South/West Node$872,759
UG1 · FY2025 · DA
Project-002$508,289
UG1 · FY2025 · DA
Project-003$364,470
UG1 · FY2025 · DA
NIDA Clinical Trials Network: Big South/West Node$5,809,886
UG1 · FY2024 · DA
NIDA Clinical Trials Network: Big South/West Node Supplemental - CURB CTN0109 & KMD CTN0132$4,935,061
UG1 · FY2024 · DA
Project-002$3,534,143
UG1 · FY2024 · DA
Center for HIV Identification, Prevention and Treatment Services$2,361,051
P30 · FY2024 · MH · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,781,880
U01 · FY2024 · DA
Administrative Core$1,461,786
P30 · FY2024 · MH · contact PI
Screen, Treat and Retain Meth-Using People with Opioid Use Disorders at MMT Clinics (STAR-OM)$359,660
R01 · FY2024 · DA
Project-003$185,304
UG1 · FY2024 · DA
Screen, Treat and Retain People with Primary Meth Use Disorder at MMT Clinics (STAR-OM+)$99,877
R01 · FY2024 · DA
Project-004$79,317
UG1 · FY2024 · DA
CORE FUNCTION ACTIVITIES TASK ORDER FOR ADVISORY SERVICES AND ADMINISTRATIVE REPORTING.$45,493
N01 · FY2024 · HD · contact PI
NIDA Clinical Trials Network: Big South/West Node$8,888,943
UG1 · FY2023 · DA
Project-002$5,063,390
UG1 · FY2023 · DA
Project-003$2,784,993
UG1 · FY2023 · DA
Center for HIV Identification, Prevention and Treatment Services$1,981,042
P30 · FY2023 · MH · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,781,880
U01 · FY2023 · DA
Project-004$1,040,560
UG1 · FY2023 · DA
Administrative Core$900,129
P30 · FY2023 · MH · contact PI
Screen, Treat and Retain Meth-Using People with Opioid Use Disorders at MMT Clinics (STAR-OM)$422,470
R01 · FY2023 · DA
Administrative Core$421,007
P30 · FY2023 · MH · contact PI
UCLA Rapid, Relevant, Rigorous Implementation Science Hub$421,007
P30 · FY2023 · MH · contact PI
Preparing for Implementation of the ATN CARES Evidence-Based Intervention Package for PrEP Uptake and Syndemic Factors among Youth$235,232
P30 · FY2023 · MH · contact PI
Administrative Core$235,232
P30 · FY2023 · MH · contact PI
Administrative Core$217,256
P30 · FY2023 · MH · contact PI
Addressing intimate partner violence, mental health burdens, and other syndemic factors to support engagement in HIV prevention services in a trans community center$217,256
P30 · FY2023 · MH · contact PI
CORE FUNCTION ACTIVITIES TASK ORDER FOR ADVISORY SERVICES AND ADMINISTRATIVE REPORTING.$45,148
N01 · FY2023 · HD · contact PI
NIDA CTN Big South/West Node Rev13 Yr18 S1 MURB$2,533,716
UG1 · FY2022 · DA
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,781,880
U01 · FY2022 · DA
Center for HIV Identification, Prevention and Treatment Services$1,500,000
P30 · FY2022 · MH · contact PI
NIDA Clinical Trials Network: Big South/West Node$781,644
UG1 · FY2022 · DA
Administrative Core$705,743
P30 · FY2022 · MH · contact PI
Screen, Treat and Retain Meth-Using People with Opioid Use Disorders at MMT Clinics (STAR-OM)$474,840
R01 · FY2022 · DA
Administrative Core$270,614
P30 · FY2022 · MH · contact PI
Applying Behavioral Economic Incentives to Support Implementation of PrEP in a Trans Community Center$270,614
P30 · FY2022 · MH · contact PI
Administrative Core$267,678
P30 · FY2022 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services$267,678
P30 · FY2022 · MH · contact PI
Administrative Core$255,495
P30 · FY2022 · MH · contact PI
Financially incentivizing HIV prevention among high-incidence populations in LA County: Preparing for implementation$255,495
P30 · FY2022 · MH · contact PI
Implementation Strategies to Promote Equitable Dissemination of Long-Acting injectable PrEP to Black/Latino MSM and Transgender Women in Los Angeles$245,539
P30 · FY2022 · MH · contact PI
Administrative Core$245,539
P30 · FY2022 · MH · contact PI
De-Medicalizing PrEP by Partnering with House and Ball Community Using Social Work and Guiding Principles: Prioritizing Young Black LGBTQ+ Individuals$241,619
P30 · FY2022 · MH · contact PI
Administrative Core$241,619
P30 · FY2022 · MH · contact PI
NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder$44,817
N01 · FY2022 · HD · contact PI
NIDA Clinical Trials Network: Big South/West Node$10,575,670
UG1 · FY2021 · DA
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,825,475
U01 · FY2021 · DA
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$1,629,038
P30 · FY2021 · MH · contact PI
Screen, Treat and Retain Meth-Using People with Opioid Use Disorders at MMT Clinics (STAR-OM)$473,025
R01 · FY2021 · DA
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$433,142
P30 · FY2021 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS) - EHE Supp: Implementation of an Emergency Department HIV/SUD screening and treatment referral mHealth tool for Latino patient$322,500
P30 · FY2021 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS) - UCLA Rapid, Relevant, Rigorous Implementation Science Hub$313,156
P30 · FY2021 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS) - EHE Supp: Developing Implementation Strategies to Optimize PrEP Delivery to Immigrant Latino MSM in Los Angeles County$247,882
P30 · FY2021 · MH · contact PI
NIDA CTN BS/WN Yr17 S1 CTN0109A1$177,192
UG1 · FY2021 · DA
NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder$47,129
N01 · FY2021 · HD · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$6,264
U01 · FY2021 · DA
NIDA CTN BS/WN Yr16 S1 CTN0109-0110$5,593,754
UG1 · FY2020 · DA
NIDA Clinical Trials Network: Big South/West Node$4,398,040
UG1 · FY2020 · DA
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,907,115
U01 · FY2020 · DA
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$1,629,056
P30 · FY2020 · MH · contact PI
Screen, Treat and Retain Meth-Using People with Opioid Use Disorders at MMT Clinics (STAR-OM)$476,502
R01 · FY2020 · DA
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$433,141
P30 · FY2020 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$250,396
P30 · FY2020 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$187,474
P30 · FY2020 · MH · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$126,000
U01 · FY2020 · DA
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,950,048
U01 · FY2019 · DA
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$1,629,074
P30 · FY2019 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$388,747
P30 · FY2019 · MH · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$165,675
U01 · FY2019 · DA
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$143,067
P30 · FY2019 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$131,400
P30 · FY2019 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$120,891
P30 · FY2019 · MH · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$9,094
U01 · FY2019 · DA
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,994,406
U01 · FY2018 · DA
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$1,631,702
P30 · FY2018 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$433,098
P30 · FY2018 · MH · contact PI
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$1,499,404
P30 · FY2017 · MH · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,488,949
U01 · FY2017 · DA
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)$507,180
P30 · FY2017 · MH · contact PI
Combating craving with contingency management: neuroplasticity and methamphetamine abuse in South Africa$9,353
R21 · FY2017 · DA · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,539,723
U01 · FY2016 · DA
Combination Prevention Core$221,664
P30 · FY2016 · MH · contact PI
Optimizing the Health of Korean Youth Using Technology for Smoking Cessation$199,057
P60 · FY2016 · MD · contact PI
Research Core$199,057
P60 · FY2016 · MD · contact PI
Combating craving with contingency management: neuroplasticity and methamphetamine abuse in South Africa$141,691
R21 · FY2016 · DA · contact PI
Combating craving with contingency management: neuroplasticity and methamphetamine abuse in South Africa$9,977
R21 · FY2016 · DA · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,401,419
U01 · FY2015 · DA
Optimizing the Health of Korean Youth Using Technology for Smoking Cessation$243,192
P60 · FY2015 · MD · contact PI
Combination Prevention Core$221,254
P30 · FY2015 · MH · contact PI
Combating craving with contingency management: neuroplasticity and methamphetamine abuse in South Africa$149,774
R21 · FY2015 · DA · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$73,920
U01 · FY2015 · DA
Research Core$29,753
P60 · FY2015 · MD · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$12,593
U01 · FY2015 · DA
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,366,414
U01 · FY2014 · DA
Combination Prevention Core$194,948
P30 · FY2014 · MH · contact PI
Optimizing the Health of Korean Youth Using Technology for Smoking Cessation$185,161
P60 · FY2014 · MD · contact PI
Research Core$185,160
P60 · FY2014 · MD · contact PI
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$9,029
U01 · FY2014 · DA
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)$1,269,402
U01 · FY2013 · DA
Varenicline for Methamphetamine Dependence$557,968
R01 · FY2013 · DA · contact PI
UCLA Training Program on Addiction Medicine in Primary Care$290,164
T32 · FY2013 · DA · contact PI
Combination Prevention Core$200,084
P30 · FY2013 · MH · contact PI
Optimizing the Health of Korean Youth Using Technology for Smoking Cessation$94,580
P60 · FY2013 · MD · contact PI
Research Core$94,579
P60 · FY2013 · MD · contact PI
Varenicline for Methamphetamine Dependence$562,525
R01 · FY2012 · DA · contact PI
UCLA Training Program on Addiction Medicine in Primary Care$294,227
T32 · FY2012 · DA · contact PI
Phase I Safety Interaction Trial of Ibudilast with Methamphetamine$232,683
R01 · FY2012 · DA · contact PI
Optimizing the Health of Korean Youth Using Technology for Smoking Cessation$214,250
P60 · FY2012 · MD · contact PI
Research Core$214,249
P60 · FY2012 · MD · contact PI
Combination Prevention Core$213,097
P30 · FY2012 · MH · contact PI
Varenicline for Methamphetamine Dependence$52,267
R01 · FY2012 · DA · contact PI
Combination Prevention Core$25,541
P30 · FY2012 · MH · contact PI
Phase I Safety Interaction Trial of Ibudilast with Methamphetamine$17,641
R01 · FY2012 · DA · contact PI
Varenicline for Methamphetamine Dependence$580,772
R01 · FY2011 · DA · contact PI
Phase I Safety Interaction Trial of Ibudilast with Methamphetamine$388,825
R01 · FY2011 · DA · contact PI
UCLA Training Program on Addiction Medicine in Primary Care$288,363
T32 · FY2011 · DA · contact PI
Phase I Safety Interaction Trial of Ibudilast with Methamphetamine$411,834
R01 · FY2010 · DA · contact PI
UCLA Training Program on Addiction Medicine in Primary Care$280,496
T32 · FY2010 · DA · contact PI
UCLA Training Program on Addiction Medicine in Primary Care$18,324
T32 · FY2010 · DA · contact PI
UCLA Medication Development Unit for Stimulant Abuse$730,994
P50 · FY2009 · DA · contact PI
Trials of Medication For Stimulant Abuse$527,889
P50 · FY2009 · DA · contact PI
UCLA Training Program on Addiction Medicine in Primary Care$134,464
T32 · FY2009 · DA · contact PI
UCLA Medication Development Unit for Stimulant Abuse$49,694
P50 · FY2009 · DA · contact PI
UCLA Medication Development Unit for Stimulant Abuse$17,764
P50 · FY2009 · DA · contact PI
UCLA Medication Development Unit for Stimulant Abuse$1,103,985
P50 · FY2008 · DA · contact PI
Trials of Medication For Stimulant Abuse$724,837
P50 · FY2008 · DA · contact PI
UCLA Medication Development Unit for Stimulant Abuse$1,130,246
P50 · FY2007 · DA · contact PI
HIV/STD Risk Behaviors in Methamphetamine User Networks$825,668
U01 · FY2007 · DA · contact PI
Trials of Medication For Stimulant Abuse$734,269
P50 · FY2007 · DA · contact PI
HIV/STD Risk Behaviors in Methamphetamine User Networks$8,599
U01 · FY2007 · DA · contact PI
HIV/STD Risk Behaviors in Methamphetamine User Networks$1,268,193
U01 · FY2006 · DA · contact PI
UCLA Medication Development Unit for Stimulant Abuse$1,164,569
P50 · FY2006 · DA · contact PI
Trials of Medication For Stimulant Abuse$570,374
P50 · FY2006 · DA · contact PI
HIV/STD Risk Behaviors in Methamphetamine User Networks$99,110
U01 · FY2006 · DA · contact PI
HIV/STD Risk Behaviors in Methamphetamine User Networks$1,100,096
U01 · FY2005 · DA
UCLA Medication Development Unit for Stimulant Abuse$400,000
P50 · FY2005 · DA
HIV/STD Risk Behaviors in Methamphetamine User Networks$98,683
U01 · FY2005 · DA
HIV/STD Risk Behaviors in Methamphetamine User Networks$81,182
U01 · FY2005 · DA
UCLA Medication Development Unit for Stimulant Abuse$1,181,023
P50 · FY2004 · DA
HIV/STD Risk Behaviors in Methamphetamine User Networks$865,649
U01 · FY2004 · DA
Trials of Medication For Stimulant Abuse$563,754
P50 · FY2004 · DA
HIV/STD Risk Behaviors in Methamphetamine User Networks$100,057
U01 · FY2004 · DA
HIV/STD Risk Behaviors in Methamphetamine User Networks$100,003
U01 · FY2004 · DA
MEDICATION DEVELOPMENT UNIT FOR STIMULANT DEPENDENCE$1,210,937
P50 · FY2003 · DA
HIV/STD Risk Behaviors in Methamphetamine User Networks$620,309
U01 · FY2003 · DA
MEDICATION DEVELOPMENT UNIT FOR STIMULANT DEPENDENCE$1,205,746
P50 · FY2002 · DA
Cocaine Rapid Evaluation Studies$165,355
P50 · FY2002 · DA
Cocaine Rapid Evaluation Studies$165,355
P50 · FY2002 · DA
MEDICATION DEVELOPMENT UNIT FOR STIMULANT DEPENDENCE$19,483
P50 · FY2002 · DA
MEDICATION DEVELOPMENT UNIT FOR STIMULANT DEPENDENCE$1,183,172
P50 · FY2001 · DA
Cocaine Rapid Evaluation Studies$165,355
P50 · FY2001 · DA
Cocaine Rapid Evaluation Studies$165,355
P50 · FY2001 · DA
MEDICATION DEVELOPMENT UNIT FOR STIMULANT DEPENDENCE$3,240
P50 · FY2001 · DA
MEDICATION DEVELOPMENT UNIT FOR STIMULANT DEPENDENCE$1,156,279
P50 · FY2000 · DA
Cocaine Rapid Evaluation Studies$477,795
P50 · FY2000 · DA
BEHAVIORAL THERAPY FOR GAY MALE METHAMPHETAMINE ABUSERS$387,839
R01 · FY2000 · DA
BEHAVIORAL THERAPY FOR GAY MALE METHAMPHETAMINE ABUSERS$4,141
R01 · FY2000 · DA